Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Anatomy (1)
- Biochemistry (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Bioethics and Medical Ethics (1)
- Biology (1)
-
- Biomedical Engineering and Bioengineering (1)
- Biotechnology (1)
- Cells (1)
- Community Health and Preventive Medicine (1)
- Engineering (1)
- Genetic Processes (1)
- Genetics (1)
- Genetics and Genomics (1)
- Genomics (1)
- Health Law and Policy (1)
- Immunity (1)
- Immunology and Infectious Disease (1)
- Immunology of Infectious Disease (1)
- Immunopathology (1)
- Immunoprophylaxis and Therapy (1)
- Infectious Disease (1)
- International Public Health (1)
- Law (1)
- Life Sciences (1)
- Medical Jurisprudence (1)
- Medical Microbiology (1)
- Medical Specialties (1)
- Institution
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Medical Genetics
Germ-Line Gene Editing And Congressional Reaction In Context: Learning From Almost 50 Years Of Congressional Reactions To Biomedical Breakthroughs, Russell A. Spivak, J.D., I. Glenn Cohen, J.D., Eli Y. Adashi, M.D., M.S.
Germ-Line Gene Editing And Congressional Reaction In Context: Learning From Almost 50 Years Of Congressional Reactions To Biomedical Breakthroughs, Russell A. Spivak, J.D., I. Glenn Cohen, J.D., Eli Y. Adashi, M.D., M.S.
Journal of Law and Health
On December 18, 2015, President Obama signed into law a policy rider forestalling the therapeutic modification of the human germ line. The rider, motivated by the science’s potential unethical ends, is only the most recent instance in which the legislature cut short the ongoing national conversation on the acceptability of a developing science. This essay offers historical perspective on what bills were proposed and passed surrounding four other then-developing scientific breakthroughs—Recombinant DNA, in vitro fertilization, Cloning, Stem Cells—to better analyze how Congress is, and should, regulate this exciting and promising science.
Hiv Vaccines: Progress, Limitations And A Crispr/Cas9 Vaccine, Omar A. Garcia Martinez
Hiv Vaccines: Progress, Limitations And A Crispr/Cas9 Vaccine, Omar A. Garcia Martinez
Biology: Student Scholarship & Creative Works
ABSTRACT: The HIV-1 pandemic continues to thrive due to ineffective HIV-1 vaccines. Historically, the world’s most infectious diseases, such as polio and smallpox, have been eradicated or have come close to eradication due to the advent of effective vaccines. Highly active antiretroviral therapy is able to delay the onset of AIDS but can neither rid the body of HIV-1 proviral DNA nor prevent further transmission. A prophylactic vaccine that prevents the various mechanisms HIV-1 has to evade and attack our immune system is needed to end the HIV-1 pandemic. Recent advances in engineered nuclease systems, like the CRISPR/Cas9 system, have …